JP2000511424A - ラクトフェリン変異体およびその使用 - Google Patents
ラクトフェリン変異体およびその使用Info
- Publication number
- JP2000511424A JP2000511424A JP09543045A JP54304597A JP2000511424A JP 2000511424 A JP2000511424 A JP 2000511424A JP 09543045 A JP09543045 A JP 09543045A JP 54304597 A JP54304597 A JP 54304597A JP 2000511424 A JP2000511424 A JP 2000511424A
- Authority
- JP
- Japan
- Prior art keywords
- lactoferrin
- iron
- vector
- binding
- mutant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/40—Transferrins, e.g. lactoferrins, ovotransferrins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/79—Transferrins, e.g. lactoferrins, ovotransferrins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmacology & Pharmacy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Toxicology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
Claims (1)
- 【特許請求の範囲】 1.ラクトフェリン変異体またはその一部がさらに少なくとも1つのラクトフェ リンの鉄結合部位に対応する配列を含むと定義され、ラクトフェリン変異体また はその一部が修飾した鉄結合能力を有するラクトフェリン変異体またはその一部 をコードする核酸配列。 2.MN-2Y、MC-2YおよびMNC-4Yよりなる群から選択されるラクトフェリン変異体 をコードする核酸配列。 3.(a)プロモーター; (b)請求項1に記載のラクトフェリン変異体またはその一部をコードするDNA; および (c)転写および翻訳開始配列および転写および翻訳終結配列;を含む組換えベ クターであって、該ベクターがラクトフェリン変異体を産生することができ、プ ロセシングしたタンパク質と同じように発現することができる組換えベクター。 4.ラクトフェリン変異体またはその一部の発現に適合したベクターであって、 該ベクターが請求項1に記載のラクトフェリン変異体またはその一部をコードす るDNAを含み、該細胞中の該DNAの発現に必要な調節配列を含むベクター。 5.(a)請求項1に記載のラクトフェリン変異体またはその一部をコードする 核酸;および (b)プロモーター、および転写および翻訳開始配列および転写および翻訳終結 配列; を含むベクターであって、該ベクターが真核生物細胞中のヒトラクトフェリンの 発現に使用されるベクター。 6.p26MN-2Y、p26MC-2Yおよびp26MNC-4Yよりなる群から選択されるベクター。 7.請求項5に記載のベクターを含む形質転換した真核生物細胞。 8.該細胞が細菌類、哺乳類および昆虫細胞よりなる群から選択される請求項7 に記載の真核生物細胞。 9.該真核生物細胞がアスペルギルス・オリゼ、黒色アスペルギルス、アスペル ギルス・ニードランスおよびアスペルギルギルス・アワモリよりなる群から選択 される細菌細胞である請求項8に記載の真核生物細胞。 10.請求項6に記載のベクターを含む形質転換した真核生物細胞。 11.該細胞が細菌類、哺乳類および昆虫細胞よりなる群から選択される請求項 10に記載の真核生物細胞。 12.該真核生物細胞がアスペルギルス・オリゼ、黒色アスペルギルス、アスペ ルギルス・ニードランスおよびアスペルギルギルス・アワモリよりなる群から選 択される細菌細胞である請求項11に記載の真核生物細胞。 13.(a)該ベクターが真核細胞中でラクトフェリン変異体およびその一部の 発現に適しており、 i)請求項1に記載の核酸;および ii)プロモーター、転写および翻訳開始配列および転写および翻訳終結配列; を含むベクターで真核生物細胞を形質転換し、 (b)ラクトフェリン変異体タンパク質が形成され栄養培地に分泌され、単離さ れるまで、適当な栄養培地において該形質転換した真核生物細胞を培養するより なる工程を含む請求項1に記載のラクトフェリン変異体またはその一部を産生す る方法。 14.請求項1に記載の核酸によってコードされるラクトフェリン変異体または その一部。 15.MN-2Y、MC-2YおよびMNC-4Yよりなる群から選択されろラクトフェリン変異 体。
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US1874796P | 1996-05-31 | 1996-05-31 | |
US60/018,747 | 1996-05-31 | ||
US08/866,544 US6111081A (en) | 1996-05-31 | 1997-05-30 | Lactoferrin variants and uses thereof |
US08/866,544 | 1997-05-30 | ||
PCT/US1997/009531 WO1997045136A1 (en) | 1996-05-31 | 1997-06-02 | Lactoferrin variants and uses thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2000511424A true JP2000511424A (ja) | 2000-09-05 |
JP2000511424A5 JP2000511424A5 (ja) | 2005-01-13 |
Family
ID=26691448
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP09543045A Ceased JP2000511424A (ja) | 1996-05-31 | 1997-06-02 | ラクトフェリン変異体およびその使用 |
Country Status (12)
Country | Link |
---|---|
US (1) | US6111081A (ja) |
EP (1) | EP0959898A4 (ja) |
JP (1) | JP2000511424A (ja) |
KR (1) | KR20000016159A (ja) |
AU (1) | AU707476B2 (ja) |
CA (1) | CA2256453A1 (ja) |
DE (1) | DE959898T1 (ja) |
ES (1) | ES2140362T1 (ja) |
GR (1) | GR990300043T1 (ja) |
IL (1) | IL127319A (ja) |
NZ (1) | NZ333215A (ja) |
WO (1) | WO1997045136A1 (ja) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2013162050A1 (ja) * | 2012-04-23 | 2013-10-31 | 株式会社Nrlファーマ | ラクトフェリン融合タンパク質及びその製造方法 |
CN104245739B (zh) * | 2012-04-23 | 2018-06-01 | Nrl制药股份有限公司 | 乳铁蛋白融合蛋白及其制备方法 |
US11041014B2 (en) | 2016-10-28 | 2021-06-22 | S & K Biopharma, Inc. | Lactoferrin/albumin fusion protein and production method therefor |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL94183A (en) * | 1989-05-05 | 2003-09-17 | Baylor College Medicine | cDNA SEQUENCE CODING FOR HUMAN LACTOFERRIN PROTEIN OR PORTION THEREOF AND LACTOFERRIN PROTEIN PRODUCED FROM SAID SEQUENCE |
EP1017407A2 (en) | 1997-02-03 | 2000-07-12 | Pharming Intellectual Property BV | Useful properties of human lactoferrin and variants thereof |
ES2245028T3 (es) * | 1997-04-10 | 2005-12-16 | Agennix, Inc. | Uso de lactoferrina en el tratamiento de trastornos inducidos por alergenos. |
US6399570B1 (en) | 1999-02-05 | 2002-06-04 | Agennix, Inc. | Antimicrobial/endotoxin neutralizing polypeptide |
US20050020484A1 (en) * | 2001-12-28 | 2005-01-27 | Etsumori Harada | Compositions for improving lipid metabolism |
US20030213007A1 (en) * | 2002-03-27 | 2003-11-13 | Slattery Charles Wilbur | Human milk produced by human mammary tissue implanted in non-human host animals and uses thereof |
ATE519499T1 (de) * | 2002-05-10 | 2011-08-15 | Agennix Inc | Lactoferrin bei der behandlung maligner neoplasien und anderer hyperproliferativer erkrankungen |
AU2003233583A1 (en) * | 2002-05-24 | 2003-12-12 | Agennix Incorporated | Oral lactoferrin in the treatment of respiratory disorders |
DK2298338T3 (da) * | 2002-09-16 | 2012-09-24 | Agennix Inc | Lactoferrin-sammensætninger og fremgangsmåder til behandling af hudsår |
EP1581243A4 (en) * | 2002-12-06 | 2008-01-02 | Agennix Inc | ORAL LACTOFERRINE FOR THE TREATMENT OF SEPSIES |
AU2003296447A1 (en) * | 2002-12-10 | 2004-06-30 | Agennix Incorporated | Lactoferrin as an agent in the prevention of organ transplant rejection and graft-versus-host-disease |
AU2002360677A1 (en) * | 2002-12-20 | 2004-07-29 | Ventria Bioscience | Lactoferrin protein with iron for treating iron deficiency and anemia |
JP2007524654A (ja) * | 2003-06-06 | 2007-08-30 | エイジェニックス インコーポレイテッド | 癌ワクチン中のアジュバントとしてのラクトフェリン |
US20040259770A1 (en) * | 2003-06-19 | 2004-12-23 | Rush University Medical Center | Method for determining leukocyte activation |
WO2005018542A2 (en) * | 2003-07-10 | 2005-03-03 | Agennix Incorporated | Use of lactoferrin in prophylaxis against infection and/or inflammation in immunosuppressed subjects |
WO2006047744A2 (en) * | 2004-10-26 | 2006-05-04 | Agennix Incorporated | Compositions of lactoferrin related peptides and uses thereof |
NZ555163A (en) | 2007-05-14 | 2010-05-28 | Fonterra Co Operative Group | Methods of immune or hematological enhancement, inhibiting tumour formation or growth, and treating or preventing cancer, cancer symptoms, or the symptoms of cancer treatments |
Family Cites Families (42)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5186117A (en) * | 1975-01-27 | 1976-07-28 | Tanabe Seiyaku Co | Johoseibiryushiseizainoseiho |
GB1575343A (en) * | 1977-05-10 | 1980-09-17 | Ici Ltd | Method for preparing liposome compositions containing biologically active compounds |
US4529561A (en) * | 1978-03-24 | 1985-07-16 | The Regents Of The University Of California | Method for producing liposomes in selected size range |
IN150740B (ja) * | 1978-11-24 | 1982-12-04 | Hoffmann La Roche | |
GB2046092B (en) * | 1979-03-05 | 1983-11-02 | Toyama Chemical Co Ltd | Pharmaceutical composition containing a lysophospholid and a phospholipid |
US4634665A (en) * | 1980-02-25 | 1987-01-06 | The Trustees Of Columbia University In The City Of New York | Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials |
US4394443A (en) * | 1980-12-18 | 1983-07-19 | Yale University | Method for cloning genes |
US4452747A (en) * | 1982-03-22 | 1984-06-05 | Klaus Gersonde | Method of and arrangement for producing lipid vesicles |
US4766075A (en) * | 1982-07-14 | 1988-08-23 | Genentech, Inc. | Human tissue plasminogen activator |
US4652639A (en) * | 1982-05-06 | 1987-03-24 | Amgen | Manufacture and expression of structural genes |
US4725442A (en) * | 1983-06-17 | 1988-02-16 | Haynes Duncan H | Microdroplets of water-insoluble drugs and injectable formulations containing same |
US4703008A (en) * | 1983-12-13 | 1987-10-27 | Kiren-Amgen, Inc. | DNA sequences encoding erythropoietin |
US4740461A (en) * | 1983-12-27 | 1988-04-26 | Genetics Institute, Inc. | Vectors and methods for transformation of eucaryotic cells |
US4710465A (en) * | 1984-04-19 | 1987-12-01 | Yale University | Junction-fragment DNA probes and probe clusters |
US5008050A (en) * | 1984-06-20 | 1991-04-16 | The Liposome Company, Inc. | Extrusion technique for producing unilamellar vesicles |
LU85479A1 (fr) * | 1984-07-25 | 1986-02-12 | Oleofina Sa | Compositions antibacteriennes de nourriture pour animaux et procede pour les preparer |
US4921706A (en) * | 1984-11-20 | 1990-05-01 | Massachusetts Institute Of Technology | Unilamellar lipid vesicles and method for their formation |
JPS61145200A (ja) * | 1984-12-19 | 1986-07-02 | Snow Brand Milk Prod Co Ltd | ウシラクトフェリンの分離精製法 |
US4886747A (en) * | 1985-03-22 | 1989-12-12 | Genentech, Inc. | Nucleic acid encoding TGF-β and its uses |
JPS6236183A (ja) * | 1985-06-20 | 1987-02-17 | ザ・サルク・インステイチユ−ト・バイオテクノロジ−/インダストリアル・アソシエイツ・インコ−ポレ−テツド | サツカロミセス・セレビシエからのポリペプチドの発現および分泌 |
FR2583676B1 (fr) * | 1985-06-24 | 1988-03-25 | Induplast Sa | Procede et appareils d'extrusion de structures alveolaires en matiere thermoplastique et structures ainsi obtenues |
US4959318A (en) * | 1985-06-27 | 1990-09-25 | Zymogenetics, Inc. | Expression of protein C |
US4800159A (en) * | 1986-02-07 | 1989-01-24 | Cetus Corporation | Process for amplifying, detecting, and/or cloning nucleic acid sequences |
US4737323A (en) * | 1986-02-13 | 1988-04-12 | Liposome Technology, Inc. | Liposome extrusion method |
US4965190A (en) * | 1986-07-31 | 1990-10-23 | Howard Hughes Medical Institute | Methods for the identification of mutations in the human phenylalanine hydroxylase gene using DNA probes |
US4920016A (en) * | 1986-12-24 | 1990-04-24 | Linear Technology, Inc. | Liposomes with enhanced circulation time |
US5009956A (en) * | 1987-02-24 | 1991-04-23 | Univ Minnesota | Phospholipase A2-resistant liposomes |
US5019508A (en) * | 1987-08-27 | 1991-05-28 | Biotechnology Research Partners, Ltd. | Synovial phospholipases |
JP2703598B2 (ja) * | 1987-09-04 | 1998-01-26 | ノボ―ノルディスク アクティーゼルスカブ | アスペルギルス菌中でのタンパク質生産物の生産方法およびアスペルギルス菌中で使用するためのプロモーター |
US5081227A (en) * | 1988-03-04 | 1992-01-14 | La Jolla Cancer Research Foundation | Germ cell alkaline phosphatase |
US4927637A (en) * | 1989-01-17 | 1990-05-22 | Liposome Technology, Inc. | Liposome extrusion method |
US4944948A (en) * | 1989-02-24 | 1990-07-31 | Liposome Technology, Inc. | EGF/Liposome gel composition and method |
US5571697A (en) * | 1989-05-05 | 1996-11-05 | Baylor College Of Medicine Texas Medical Center | Expression of processed recombinant lactoferrin and lactoferrin polypeptide fragments from a fusion product in Aspergillus |
US5571691A (en) * | 1989-05-05 | 1996-11-05 | Baylor College Of Medicine | Production of recombinant lactoferrin and lactoferrin polypeptides using CDNA sequences in various organisms |
US5155037A (en) * | 1989-08-04 | 1992-10-13 | The Texas A&M University System | Insect signal sequences useful to improve the efficiency of processing and secretion of foreign genes in insect systems |
IL95697A0 (en) * | 1989-09-28 | 1991-06-30 | Granada Biosciences Inc | Cdna sequence for porcine lactoferrin protein |
WO1991013982A1 (en) * | 1990-03-08 | 1991-09-19 | Ferrodynamics, Inc. | Genetically engineered human lactoferrin |
JP2818056B2 (ja) * | 1990-09-07 | 1998-10-30 | 森永乳業株式会社 | 抗菌性ペプチドおよび抗菌剤 |
US5166145A (en) * | 1990-09-10 | 1992-11-24 | Alza Corporation | Antiemetic therapy |
NZ245713A (en) * | 1992-02-10 | 1994-12-22 | Novopharm Ltd | Production of the antibiotic lovastatin from genetically engineered aspergillus strains |
ZA932568B (en) * | 1992-04-24 | 1993-11-12 | Baylor College Midecine A Non | Production of recombinant human lactoferrin |
US5571619A (en) * | 1994-05-24 | 1996-11-05 | Exxon Chemical Patents, Inc. | Fibers and oriented films of polypropylene higher α-olefin copolymers |
-
1997
- 1997-05-30 US US08/866,544 patent/US6111081A/en not_active Expired - Lifetime
- 1997-06-02 IL IL12731997A patent/IL127319A/en not_active IP Right Cessation
- 1997-06-02 GR GR990300043T patent/GR990300043T1/el unknown
- 1997-06-02 JP JP09543045A patent/JP2000511424A/ja not_active Ceased
- 1997-06-02 DE DE0959898T patent/DE959898T1/de active Pending
- 1997-06-02 KR KR1019980709727A patent/KR20000016159A/ko not_active Application Discontinuation
- 1997-06-02 CA CA002256453A patent/CA2256453A1/en not_active Abandoned
- 1997-06-02 NZ NZ333215A patent/NZ333215A/xx not_active IP Right Cessation
- 1997-06-02 WO PCT/US1997/009531 patent/WO1997045136A1/en not_active Application Discontinuation
- 1997-06-02 ES ES97927932T patent/ES2140362T1/es active Pending
- 1997-06-02 AU AU32271/97A patent/AU707476B2/en not_active Ceased
- 1997-06-02 EP EP97927932A patent/EP0959898A4/en not_active Withdrawn
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2013162050A1 (ja) * | 2012-04-23 | 2013-10-31 | 株式会社Nrlファーマ | ラクトフェリン融合タンパク質及びその製造方法 |
CN104245739A (zh) * | 2012-04-23 | 2014-12-24 | Nrl制药股份有限公司 | 乳铁蛋白融合蛋白及其制备方法 |
JPWO2013162050A1 (ja) * | 2012-04-23 | 2015-12-24 | 株式会社Nrlファーマ | ラクトフェリン融合タンパク質及びその製造方法 |
JP2016117717A (ja) * | 2012-04-23 | 2016-06-30 | 株式会社Nrlファーマ | ラクトフェリン融合タンパク質及びその製造方法 |
US9809641B2 (en) | 2012-04-23 | 2017-11-07 | Nrl Pharma, Inc. | Lactoferrin fusion protein and method for preparation thereof |
CN104245739B (zh) * | 2012-04-23 | 2018-06-01 | Nrl制药股份有限公司 | 乳铁蛋白融合蛋白及其制备方法 |
US10562959B2 (en) | 2012-04-23 | 2020-02-18 | Nrl Pharma, Inc. | Lactoferrin fusion protein and method for preparation thereof |
US11041014B2 (en) | 2016-10-28 | 2021-06-22 | S & K Biopharma, Inc. | Lactoferrin/albumin fusion protein and production method therefor |
Also Published As
Publication number | Publication date |
---|---|
DE959898T1 (de) | 2000-05-04 |
NZ333215A (en) | 2000-05-26 |
AU3227197A (en) | 1998-01-05 |
KR20000016159A (ko) | 2000-03-25 |
US6111081A (en) | 2000-08-29 |
EP0959898A1 (en) | 1999-12-01 |
WO1997045136A1 (en) | 1997-12-04 |
IL127319A (en) | 2004-08-31 |
EP0959898A4 (en) | 2002-08-14 |
ES2140362T1 (es) | 2000-03-01 |
GR990300043T1 (en) | 2000-01-31 |
CA2256453A1 (en) | 1997-12-04 |
IL127319A0 (en) | 1999-09-22 |
AU707476B2 (en) | 1999-07-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2000511424A (ja) | ラクトフェリン変異体およびその使用 | |
TW458984B (en) | Novel mutant hIL-4 proteins as antagonists or partial agonists of human interleukin 4 | |
WO1997045136A9 (en) | Lactoferrin variants and uses thereof | |
CN103079586B (zh) | G‑csf二聚体在治疗嗜中性粒细胞减少症中的应用 | |
JP2009521932A (ja) | 抗菌性カテリシジンペプチド | |
JPH08511167A (ja) | ケモカインの生物学的活性の強化法 | |
WO2023284684A1 (zh) | 一种乳源多肽衍生物及其在制备肥胖症防治药物、保健品和食品添加物中的应用 | |
JPS62174026A (ja) | 白血球減少症治療剤 | |
US20100061961A1 (en) | Recombinant super-compound interferon | |
JP2011503137A (ja) | 新規のアルギニン置換ペプチド及びその使用 | |
CN106552259A (zh) | 一种融合蛋白及其治疗疾病的用途 | |
JP2012511309A (ja) | Ec−sodのカルボキシル末端のアポプチンタンパク質導入ドメインの融合蛋白質 | |
JP2002516339A5 (ja) | LAIT(sCD14)蛋白質による抗生物質ペプチドの誘導 | |
TW420688B (en) | Mpl ligand analogs | |
JP2004533846A (ja) | 生物学的に活性なペプチド | |
CN112194730A (zh) | 一种多肽ti-16及其用途 | |
JP2001526537A (ja) | 敗血症の治療法 | |
JP2000505791A (ja) | 肥満症タンパク質類似体化合物およびその製剤 | |
US20230416326A1 (en) | Modified interleukin-2 (il-2) molecule and use thereof | |
WO1999055864A1 (fr) | Nouveau polypeptide, adnc le codant et son utilisation | |
MX2010010795A (es) | Uso de defensinas contra meningitis. | |
WO1999033873A1 (fr) | NOUVEAUX POLYPEPTIDES, ADNc CODANT CES POLYPEPTIDES ET UTILISATION DE CEUX-CI | |
WO2023151594A1 (en) | A composition comprising gip receptor agonists and glp-1 receptor agonists and use thereof | |
WO2000008056A1 (fr) | NOUVEAU POLYPEPTIDE, ADNc LE CODANT ET SON UTILISATION | |
MXPA98010080A (en) | Variants of lactoferrina and uses of the mi |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20040527 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20040527 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20061121 |
|
A313 | Final decision of rejection without a dissenting response from the applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A313 Effective date: 20070413 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20070522 |